Stocks Health care PBH
NYSE · Health carePrestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. brought in $1.2B of revenue over the twelve months to September 30, 2026, up 5.1% from a year earlier. Net income was $155.1M, a net margin of 13.3%. Operating cash flow minus capital spending left $246.4M of free cash flow in fiscal 2026. At September 30, 2026 it held $46.5M in cash against $2.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Prestige Consumer Healthcare Inc.
- Net worth
- Prestige Consumer Healthcare Inc. has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $1.9B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $1.1B (-4.3% year on year), with net income of $190.3M. Over the 12 months to September 30, 2026: revenue $1.2B, net income $155.1M.
- Cash flow
- In fiscal 2026 operations brought in $257.6M of cash; after $11.2M of capital spending, free cash flow was $246.4M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Prestige Consumer Healthcare Inc.'s next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Prestige Consumer Healthcare Inc. does
Prestige Consumer Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker PBH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $1.1B | $190.3M | $3.91 | $246.4M |
| 2025 | $1.1B | $214.6M | $4.29 | $243.3M |
| 2024 | $1.1B | $209.3M | $4.17 | $239.4M |
| 2023 | $1.1B | -$82.3M | -$1.65 | $221.9M |
| 2022 | $1.1B | $205.4M | $4.04 | $250.3M |
| 2021 | $943.4M | $164.7M | $3.25 | $213.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PBH ranks in Health care
Latest SEC filings
What Prestige Consumer Healthcare Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 23% to $336.3M versus the same quarter last year; diluted EPS $0.53 versus $0.86.
- November 5, 2026
- August 14, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 6.5% to $265.7M versus the same quarter last year; diluted EPS $0.61 versus $0.95.
- August 6, 2026
- July 15, 2026
- July 9, 2026Exhibits 8-K/A
- July 7, 2026Passive stake changed SCHEDULE 13G/A
- July 6, 2026
- June 30, 2026Exhibits 8-K/A
What is PBH worth? A DCF from its reported cash flow
Insider trades
What the people running Prestige Consumer Healthcare Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 4, 2026 | Byom John EDirector | Received as pay | 2,981 | - |
| August 4, 2026 | Clark Celeste A.Director | Received as pay | 2,981 | - |
| August 4, 2026 | DArecca JamesDirector | Received as pay | 2,981 | - |
| August 4, 2026 | Kelly John F.Director | Received as pay | 2,981 | - |
| August 4, 2026 | Zier Dawn M.Director | Received as pay | 2,981 | - |
| May 11, 2026 | Zerillo JeffreySenior VP Operations | Soldpre-planned (10b5-1) | 351 | $18.4K |
| May 7, 2026 | Mekhail AdelEVP, Marketing & Sales | Shares withheld for tax | 487 | $26.6K |
| May 7, 2026 | Lombardi Ronald M.Chief Executive Officer, Director | Shares withheld for tax | 2,543 | $138.8K |
Who owns PBH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ariel Investments, LLC13G, passive | 10.3% | July 7, 2026 |
| Vanguard Portfolio Management13G, passive | 5.97% | April 29, 2026 |
| Dimensional Fund Advisors LP13G, passive | 5.9% | January 23, 2025 |
| Vanguard Capital Management13G, passive | 5.18% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 318 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 7,831,333 | +442,843 |
| Ariel Investments, LLC | 4,868,711 | +594,385 |
| Vanguard Portfolio Management LLC | 2,825,340 | +21,512 |
| Dimensional Fund Advisors LP | 2,661,291 | -11,486 |
| Fuller & Thaler Asset Management, Inc. | 2,331,821 | new |
| Vanguard Capital Management LLC | 2,136,944 | +43,951 |
| State Street Corp | 2,116,513 | +145,532 |
| Brandes Investment Partners, LP | 2,051,060 | +1,196,941 |
| Kayne Anderson Rudnick Investment Management LLC | 1,872,023 | -330,583 |
| Geode Capital Management, LLC | 1,571,742 | +111,707 |
| Allspring Global Investments Holdings, LLC | 1,271,950 | -286,154 |
| Morgan Stanley | 1,243,931 | -113,539 |
| Nordea Investment Management AB | 828,628 | +229,253 |
| Northern Trust Corp | 773,449 | +23,144 |
| Westwood Holdings Group Inc | 750,445 | -369,270 |
| Rice Hall James & Associates, LLC | 689,692 | +168,070 |
| Manufacturers Life Insurance Company, The | 658,659 | +185,508 |
| Charles Schwab Investment Management Inc | 654,174 | -87,975 |
| UBS Group AG | 638,605 | +246,396 |
| Massachusetts Financial Services Co | 629,836 | +31,810 |
Insiders
11 insiders reported holding 652,203 shares in total, about $28.5M at the last price.
| Holder | Shares |
|---|---|
| Lombardi Ronald M.Chief Executive Officer, Director | 373,465 |
| Sacco ChristineCFO & COO | 71,636 |
| Byom John EDirector | 54,575 |
| Zerillo JeffreySenior VP Operations | 41,810 |
| P'Pool WilliamSee Remarks | 28,149 |
| Mekhail AdelEVP, Marketing & Sales | 25,703 |
| Zier Dawn M.Director | 19,514 |
| Clark Celeste A.Director | 16,511 |
| DArecca JamesDirector | 9,572 |
| Kelly John F.Director | 7,832 |
Questions about PBH
What does Prestige Consumer Healthcare Inc. do?
Prestige Consumer Healthcare Inc. is a company in the Health care sector, listed on NYSE as PBH. Its shares trade on NYSE under the ticker PBH.
What is Prestige Consumer Healthcare Inc.'s net worth?
Prestige Consumer Healthcare Inc. has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $1.9B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Prestige Consumer Healthcare Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $155.1M on revenue of $1.2B, a net margin of 13.3%.
How much revenue does Prestige Consumer Healthcare Inc. make?
Over the twelve months to September 30, 2026 Prestige Consumer Healthcare Inc. reported revenue of $1.2B. That is 5.1% more than a year earlier.
When did Prestige Consumer Healthcare Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Prestige Consumer Healthcare Inc.'s next earnings report?
Prestige Consumer Healthcare Inc.'s next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PBH with
Follow PBH
Get an email when Prestige Consumer Healthcare Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Prestige Consumer Healthcare Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.